<--- Back to Details
| First Page | Document Content | |
|---|---|---|
 Date: 2016-07-11 17:00:28Medicine Health care Health Rheumatology Inborn errors of purine-pyrimidine metabolism Uric acid Pegloticase Savient pharmaceuticals Gout Tophus Hyperuricemia Clinical trial |
Add to Reading List |
Microsoft Word - Savient press release re ACRdoc | Microsoft Word - FDA Grants Priority Review to Pegloticase BLA FilingdocDocID: 1sopU - View Document |
 | Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1 Conjugates prepared with aggregate-free proteins - European Patent Office - EPB1DocID: 1rrGr - View Document |
 | Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1 Peg-urate oxidase conjugates and use thereof - European Patent Office - EPB1DocID: 1rrm1 - View Document |
 | Microsoft Word - Savient Press Release ACRdocDocID: 1rrcY - View Document |
 | Microsoft Word - Savient Phase 3 Dosing press releasedocDocID: 1ri7E - View Document |